A detailed history of Orion Portfolio Solutions, LLC transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Orion Portfolio Solutions, LLC holds 2,590 shares of PCVX stock, worth $222,506. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,590
Previous 4,581 43.46%
Holding current value
$222,506
Previous $345,000 14.49%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

SELL
$70.52 - $117.12 $140,405 - $233,185
-1,991 Reduced 43.46%
2,590 $295,000
Q2 2024

Aug 13, 2024

SELL
$60.06 - $78.77 $16,036 - $21,031
-267 Reduced 5.51%
4,581 $345,000
Q1 2024

May 09, 2024

SELL
$59.79 - $81.05 $146,904 - $199,139
-2,457 Reduced 33.63%
4,848 $331,000
Q4 2023

Feb 09, 2024

BUY
$45.35 - $63.41 $47,617 - $66,580
1,050 Added 16.79%
7,305 $458,000
Q3 2023

Nov 01, 2023

BUY
$46.0 - $53.1 $287,730 - $332,140
6,255 New
6,255 $318,000

Others Institutions Holding PCVX

About Vaxcyte, Inc.


  • Ticker PCVX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,315,100
  • Market Cap $5.1B
  • Description
  • Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...
More about PCVX
Track This Portfolio

Track Orion Portfolio Solutions, LLC Portfolio

Follow Orion Portfolio Solutions, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Orion Portfolio Solutions, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orion Portfolio Solutions, LLC with notifications on news.